F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder

Name of the Condition

• Other Psychoactive Substance Dependence with Psychoactive Substance-Induced Anxiety Disorder
• ICD-10 Code: F19.280

Summary

This condition involves a pattern of dependence on non-classified psychoactive substances (excluding alcohol, opioids, or cannabis) that is complicated by co-occurring anxiety symptoms directly resulting from substance use. Dependence is marked by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences. The induced anxiety disorder may include symptoms such as excessive worry, restlessness, or panic attacks triggered by the substance's pharmacological effects.

Causes

The causes include chronic use of psychoactive substances that alter brain function, psychological factors such as stress or trauma, and social influences like peer pressure. The addictive potential of these substances, combined with repeated use, can lead to dependence. Induced anxiety arises from the direct pharmacological effects of the substance on the central nervous system, disrupting neurotransmitter balance and triggering anxiety-related symptoms.

Risk Factors

• Genetic predisposition to addiction
• Co-occurring mental health disorders (e.g., anxiety, depression)
• Early exposure to psychoactive substances
• Environmental factors (e.g., access to substances, social norms)

Symptoms

• Intense cravings or urges to use the substance
• Inability to reduce or control use despite efforts
• Withdrawal symptoms when not using (e.g., irritability, fatigue)
• Excessive worry or restlessness related to substance use
• Panic attacks or physical symptoms of anxiety (e.g., rapid heartbeat, sweating)
• Neglect of personal, occupational, or social responsibilities

Diagnosis

Diagnosis typically involves a thorough medical and psychological evaluation, including patient self-reports of substance use patterns and anxiety symptoms. Clinicians assess whether symptoms are directly attributable to substance use (e.g., onset, duration, and remission tied to use) and rule out other causes of anxiety. Standardized questionnaires or clinical interviews may be used to confirm dependence and induced anxiety.

Treatment Options

Treatment may include behavioral therapies (e.g., cognitive-behavioral therapy) to address dependence and anxiety, medication to manage withdrawal or anxiety symptoms, and support groups. A multidisciplinary approach involving mental health professionals and addiction specialists is often recommended to address both substance use and co-occurring disorders.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, adherence to treatment, and presence of co-occurring conditions. Regular follow-up is essential to monitor progress, adjust treatment, and prevent relapse. Long-term management may be necessary to sustain recovery and manage anxiety symptoms.

Complications

Complications can include worsening anxiety, substance-related health issues (e.g., organ damage), social or occupational impairment, and increased risk of overdose or other substance-related harm.

Lifestyle & Prevention

Lifestyle modifications may include avoiding triggers, building a support network, and engaging in stress-reduction techniques. Prevention focuses on education about the risks of psychoactive substance use and early intervention for at-risk individuals.

When to Seek Professional Help

Seek help if substance use is uncontrollable, anxiety symptoms interfere with daily life, or withdrawal symptoms occur. Immediate care is needed for severe anxiety, suicidal thoughts, or signs of overdose.

Tips for Medical Coders

Document the specific psychoactive substance involved, the pattern of dependence (e.g., tolerance, withdrawal), and the presence of substance-induced anxiety symptoms. Ensure clinical notes link anxiety symptoms directly to substance use to support the diagnosis. Code F19.280 is appropriate when anxiety is the primary induced disorder; specify other induced disorders if applicable.